Richmond Brothers, Inc. Oncternal Therapeutics, Inc. Transaction History

Richmond Brothers, Inc.

  • $161 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 02, 2023
BUY
$0.29 - $0.48 $58,872 - $97,444
203,010 Added 69.76%
494,042 $148,000
Q2 2023

Aug 11, 2023
BUY
$0.28 - $0.79 $70,747 - $199,609
252,670 Added 658.65%
291,032 $98,000
Q1 2023

May 10, 2023
BUY
$0.63 - $1.3 $24,168 - $49,870
38,362 New
38,362 $30,000

Others Institutions Holding ONCT

# of Institutions
3
Shares Held
362K
Call Options Held
0
Put Options Held
0
View Full List

About Oncternal Therapeutics, Inc.

ONCT Quotes by TradingView
  • Ticker ONCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,517,200
  • Market Cap $29.4M
  • Description
  • Oncternal Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of oncology therapies for cancers with critical unmet medical needs. The company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to receptor-tyrosine kinase-like Orphan Receptor 1 (ROR1); and ONCT-216, a smal...
More about ONCT
Track This Portfolio

Track Richmond Brothers, Inc. Portfolio

Follow Richmond Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richmond Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Richmond Brothers, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email